In re: Galectin Therapeutics, Inc. Securities Litigation, No. 16-10324, 2016 WL 7240146, ____ , F2d ___ (11th Cir. Dec. 15, 2016).
The Eleventh Circuit recently addressed the circumstances under which a public company...more
12/20/2016
/ Disclosure Requirements ,
Financial Markets ,
Pharmaceutical Industry ,
Public Offerings ,
Publicly-Traded Companies ,
Rule 10(b) ,
Securities ,
Securities Exchange Act ,
Securities Fraud ,
Securities Litigation ,
Securities Violations ,
Stock Promoters ,
Stocks ,
Third-Party Agents
S.E.C. v. Radius Capital Corp., No. 15-12004, 2016 WL 3542235, ___ F. App’x ___ (11th Cir. June 29, 2016).
The Eleventh Circuit last month explained the material similarities and differences between two kinds of...more
7/14/2016
/ Federal Housing Administration (FHA) ,
Financial Institutions ,
Financial Markets ,
Ginnie Mae ,
Misrepresentation ,
Mortgage Lenders ,
Mortgage-Backed Securities ,
Mortgages ,
Rule 10(b) ,
Rule 10b-5 ,
Section 17(a) ,
Securities Act of 1933 ,
Securities Exchange Act ,
Securities Violations